Balyasny Asset Management
CELG

Balyasny Asset Management’s Celgene Corp CELG Stock Holding History

Balyasny Asset Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-205,000
Closed -$19.3M – 1867
2019
Q1 		$19.3M Buy
+205,000
New +$17.9M 0.13% 230
2017
Q3 		– Sell
-130,000
Closed -$16.9M – 2234
2017
Q2 		$16.9M Buy
+130,000
New +$15.9M 0.07% 372
2015
Q2 		– Sell
-300,000
Closed -$34.6M – 1504
2015
Q1 		$34.6M Buy
+300,000
New +$35.8M 0.28% 100

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Balyasny Asset Management's CELG Position: Q4 2019 in Review

Balyasny Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 993,429 shares — an estimated $98.6M sold.

Balyasny Asset Management first reported a position in CELG in Q2 2013 and held it in 19 quarters. The position peaked at $98.6M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Balyasny Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Balyasny Asset Management sold 993,429 Celgene Corp shares in Q4 2019, an estimated $98.6M.
  • Balyasny Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 19 quarters.
  • Balyasny Asset Management's Celgene Corp position peaked at $98.6M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Balyasny Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.